The Kremlin spokesman says Russia considers plans by G7 nations to offer Ukraine security guarantees “extremely ill-judged and potentially very dangerous.”
Illumina is a major supplier of next-generation sequencing systems for genetic and genomic analysis, while Grail is a health company developing blood tests to try to catch cancer early.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: